InsidersTradesSigma
Track the LIGAND PHARMACEUTICALS INCORPORATED share price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on US US, under the supervision of SEC (Form 4). The latest transaction was disclosed on 1 July 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: ANDREW REARDON. Every trade is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration